April 26 (Reuters) - Yourgene Health PLC YGEN.L :
* FULL YEAR TRADING UPDATE
* FY REVENUE ROSE 105 PERCENT TO 37.6 MILLION STG
* : FY22 PERFORMANCE IN LINE WITH UPGRADED GUIDANCE
* : REVENUES DOMINATED BY COVID PCR TESTING AND VARIANT
SEQUENCING
* : TESTING CAPACITY CONTINUES TO BE REPURPOSED TOWARDS
NON-COVID
TESTING
* : PRIVATE COVID-19 TESTING CONTINUES ALBEIT AT MORE MODEST
LEVELS
* : RESTRUCTURE COMMENCED IN FINAL QUARTER OF FY22 AND WILL
BE
LARGELY COMPLETE BY END OF Q1 OF FY23
Source text for Eikon: ID:nRSZ2776Ja
Further company coverage: YGEN.L
((Reuters.Briefs@thomsonreuters.com;;))